Nika Pharmaceuticals, Inc (NIKA) Shares Outstanding (2021 - 2023)

Nika Pharmaceuticals (NIKA) has 3 years of Shares Outstanding (Entity) data on file, last reported at $876.1 million in Q4 2023.

• Quarterly Shares Outstanding (Entity) rose 21.01% year-over-year to $876.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $876.1 million (up 21.01% YoY) and the FY2023 annual result came in at $876.1 million, up 21.01% from the prior year.
• Shares Outstanding (Entity) held at $876.1 million in Q4 2023, from $876.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $876.1 million in Q2 2022 to a low of $13.2 million in Q1 2021.
• A 3-year average of $503.9 million and a median of $800.0 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The widest YoY moves for Shares Outstanding (Entity): up 6535.54% in 2022, down 0.0% in 2022.
• Tracing NIKA's Shares Outstanding (Entity) over 3 years: stood at $13.2 million in 2021, then jumped by 5383.25% to $724.0 million in 2022, then gained by 21.01% to $876.1 million in 2023.
• The last three Shares Outstanding (Entity) figures came in at $876.1 million (Q4 2023), $876.1 million (Q3 2023), and $876.1 million (Q2 2023), per Business Quant data.